top of page
it's where dermatology lives
John Evans
Oct 28, 20222 min read
Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery
Findings from a study of patients with stage III melanoma treated with a combination of the immune checkpoint inhibitors relatlimab and...
John Evans
Jan 7, 20222 min read
Combination LAG-3/PD-1 inhibition superior to PD-1 inhibition monotherapy for metastatic melanoma
Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...
Featured Posts
bottom of page